Oral Micronized Progesterone Cost in Kansas (2026)

What Does Oral Micronized Progesterone Cost in Kansas?

Cash-pay prices for oral micronized progesterone in Kansas vary widely by pharmacy, dose, and whether you use a brand or generic. The manufacturer list price for Prometrium sits at $180 per month, but almost no cash-pay patient actually pays that. Across Kansas retail pharmacies in 2026, the average out-of-pocket cost is approximately $45 per month for a 30-day supply of 200 mg capsules.

Brand vs. Generic Pricing

Prometrium is the original brand, manufactured by Solvay Pharmaceuticals (now AbbVie). Multiple FDA-approved generic versions have been on the market since 2014. At most Kansas pharmacies, the generic 200 mg capsule runs $35 to $55 per month without a discount card, while Prometrium itself ranges from $80 to $160 depending on the pharmacy.

Switching to a generic requires only a brief conversation with your prescriber or pharmacist, since FDA bioequivalence standards require generics to deliver the same active ingredient at the same dose. The FDA's product labeling for oral progesterone is publicly searchable through the FDA accessdata portal.

Why List Price and Cash Price Diverge So Much

Pharmacy benefit managers negotiate rebates that never reach the uninsured patient. The spread between list price and actual acquisition cost for oral micronized progesterone is unusually large because the drug has been available as a generic for over a decade. Independent Kansas pharmacies often price generics near acquisition cost, while big-box chains price to their internal formulary benchmarks. Calling three to four pharmacies in your ZIP code before filling the prescription may save $20 or more per month.

Does Kansas Medicaid Cover Oral Micronized Progesterone?

Kansas Medicaid (KanCare) does not cover oral micronized progesterone for menopausal hormone-replacement therapy. The drug appears on the KanCare preferred drug list only for type 2 diabetes-adjacent endocrinological indications, not for endometrial protection in postmenopausal estrogen users.

What KanCare Will and Won't Pay For

If you are a KanCare enrollee using oral micronized progesterone as part of HRT, you will likely face a denial at the pharmacy counter. A prior authorization (PA) request is still worth filing if your prescriber can document a medically necessary indication beyond routine HRT, such as abnormal uterine bleeding or documented luteal phase deficiency. Denials can be appealed through KanCare's standard grievance process within 90 days of the adverse decision.

Exceptions Worth Asking About

Certain managed care organizations within KanCare, including Aetna Better Health of Kansas, Sunflower Health Plan, and United Healthcare Community Plan, maintain their own drug formularies. Formularies change on a quarterly basis. Calling the member services number on your KanCare card to request the current formulary PDF is faster than waiting on hold with the state pharmacy help line.

Is Compounded Progesterone Legal in Kansas?

Yes. Licensed 503A compounding pharmacies in Kansas may legally prepare oral micronized progesterone capsules for individual patients who hold a valid prescription from a licensed prescriber. Under Section 503A of the federal Food, Drug, and Cosmetic Act, patient-specific compounding is permissible even for drugs that have an FDA-approved commercial equivalent, provided a pharmacist-patient relationship exists and the compounding is not done in anticipation of prescriptions.

How 503A Compounding Works

A 503A pharmacy compounds one prescription at a time for a named patient. In Kansas, the Board of Pharmacy licenses and inspects compounding pharmacies to confirm compliance with United States Pharmacopeia (USP) Chapter 795 standards for non-sterile preparations. Oral capsules fall under this category. Compounded oral micronized progesterone from a Kansas-licensed 503A pharmacy costs approximately $25 per month, roughly 44% less than average retail cash pricing.

503A vs. 503B: Which Can Ship to Kansas Patients?

503B outsourcing facilities are large-scale compounders registered with the FDA. They may compound without a patient-specific prescription but cannot dispense directly to patients. A Kansas-licensed 503A pharmacy that also holds an out-of-state pharmacy license may ship compounded progesterone to Kansas patients, which is relevant for telehealth patients whose prescriber works through a national platform. Confirm the pharmacy holds an active Kansas permit before accepting a dispensed product.

What Compounding Cannot Do

Compounded products lack the bioequivalence data and stability testing that accompany FDA-approved products. The clinical trials establishing progesterone's endometrial-protection benefit, most notably the PEPI Trial (N=875), used the micronized form in peanut oil carriers equivalent to what Prometrium contains. A compounded capsule using a different excipient may have different absorption kinetics, so patients switching between compounded and commercial products should discuss this with their provider. The PEPI Trial results were published in JAMA in 1995.

Clinical Basis for Oral Micronized Progesterone in HRT

Understanding why oral micronized progesterone is prescribed helps explain why cost matters: it is a long-term medication, not a short course. Women with an intact uterus who use systemic estrogen for menopause symptoms require a progestogen to protect the endometrium from hyperplasia and potential malignancy.

The PEPI Trial (1995)

The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial enrolled 875 healthy postmenopausal women and followed them for three years. Participants receiving conjugated equine estrogen plus oral micronized progesterone experienced favorable lipid profiles (HDL-C changes of +1.6 mg/dL vs. +4.1 mg/dL for estrogen alone) while maintaining endometrial safety comparable to synthetic progestins. Full PEPI results are indexed on PubMed.

The Writing Group for the PEPI Trial stated directly: "Among women with a uterus, CEE alone caused a high rate of adenomatous or atypical hyperplasia. Progestogen use prevented this effect."

FDA Approval and Labeled Indications

The FDA approved Prometrium in 1998 for two indications: prevention of endometrial hyperplasia in non-hysterectomized postmenopausal women receiving conjugated estrogens, and secondary amenorrhea. The approved doses are 200 mg nightly for 12 days per 28-day cycle (cyclic regimen) or 100 mg nightly (continuous regimen). Prescribers sometimes use 200 mg continuous for women who experience breakthrough bleeding on the lower dose, though this represents off-label use. Product labeling details are available through the FDA accessdata portal.

A 2022 review published in Menopause confirmed that oral micronized progesterone is associated with lower rates of breast cancer signal compared to synthetic progestins in observational data, though no randomized trial has been powered to detect that difference directly.

Micronized vs. Synthetic Progestins: A Quick Distinction

Oral micronized progesterone is bioidentical, meaning the molecular structure is identical to endogenous progesterone. Synthetic progestins such as medroxyprogesterone acetate (MPA) bind progesterone receptors but also have partial activity at androgen and glucocorticoid receptors, which accounts for some of their differing side-effect profiles. The distinction matters clinically and financially: MPA-containing regimens are typically less expensive, so insurers sometimes prefer them on formulary.

Insurance Coverage for Oral Micronized Progesterone in Kansas

Private insurance coverage for oral micronized progesterone in Kansas is inconsistent but more accessible than Medicaid. Most commercial plans in Kansas, including BCBS of Kansas, Aetna, Cigna, and UnitedHealthcare individual and employer plans, list a generic oral micronized progesterone on Tier 2 or Tier 3 of their formularies.

Tier Placement and What It Means for Your Copay

Tier 2 typically carries a $20 to $50 copay per month. Tier 3 copays range from $50 to $100. If your plan places brand Prometrium on Tier 3 or non-preferred, requesting a PA for the generic usually resolves the issue without requiring a step-therapy process, because the generic is therapeutically equivalent. Ask your prescriber's office to submit the PA with the ICD-10 code N95.1 (menopausal and female climacteric states) and Z79.890 (hormone replacement therapy status).

ACA Marketplace Plans in Kansas

Kansas uses the federally facilitated marketplace (healthcare.gov). Plans sold through the marketplace are required by the ACA to cover preventive services rated A or B by the USPSTF at no cost sharing. Menopausal hormone therapy for women 50 and older is not yet rated A or B by the U.S. Preventive Services Task Force for primary disease prevention, which means cost-sharing exemptions do not automatically apply. Coverage terms therefore vary by plan and network.

Employer-Sponsored Plans

Large self-funded employer plans in Kansas may follow different formulary rules than state-regulated plans. If your employer contracts with a pharmacy benefit manager (PBM) such as CVS Caremark or Express Scripts, their national preferred drug list likely includes a generic progesterone at Tier 2. Confirming your specific plan's formulary via the benefits portal or by calling the PBM directly will yield the most accurate copay estimate.

The Cheapest Ways to Get Oral Micronized Progesterone in Kansas

Getting the lowest possible price requires combining the right pharmacy channel with a coupon or manufacturer program.

GoodRx and Comparable Coupon Platforms

GoodRx, RxSaver, and NeedyMeds all publish negotiated cash prices at specific Kansas pharmacies. In Wichita, for example, GoodRx prices for generic progesterone 200 mg (30 capsules) ranged from $18 to $52 across 12 pharmacies in early 2025, with independent pharmacies consistently at the lower end. These coupons cannot be combined with insurance, so patients should compare their insurance copay against the coupon price before choosing at the counter.

Manufacturer Savings Cards

AbbVie (which markets Prometrium) offers a savings card for commercially insured patients that may reduce the out-of-pocket cost to as low as $30 per month on brand Prometrium. The card is not valid for government-insured patients (Medicaid, Medicare, TRICARE). Terms change annually, so verifying current limits on the AbbVie patient support website before the prescription is filled avoids surprises.

503A Compounding Pharmacies

At approximately $25 per month, a licensed Kansas 503A compounding pharmacy represents the lowest-cost option for most cash-pay patients who do not qualify for manufacturer savings programs. The prescriber must write the prescription specifying compounded oral micronized progesterone, the dose in mg, quantity, and instructions. Some telehealth platforms in Kansas partner directly with compounding pharmacies and include the consultation fee in a bundled monthly subscription, which may bring total cost below $60 per month including the prescriber visit.

90-Day Supply Pricing

Requesting a 90-day supply instead of 30 days typically drops the per-unit cost by 10 to 15%. Mail-order pharmacies affiliated with most Kansas insurance plans charge the equivalent of two monthly copays for a three-month supply. At GoodRx cash prices, a 90-day supply of generic progesterone 200 mg in Overland Park runs approximately $45, or $15 per month.

Kansas Cost Decision Framework: Oral Micronized Progesterone

| Patient Situation | Recommended First Step | Expected Monthly Cost | |---|---|---| | Commercial insurance, generic on formulary | Use insurance Tier 2 copay | $20 to $50 | | Commercial insurance, Prometrium preferred | PA for generic or AbbVie savings card | $30 to $50 | | KanCare / Medicaid | File PA with clinical documentation; appeal if denied | $0 if approved, full cash price if denied | | Uninsured, cash-pay | GoodRx coupon at independent pharmacy | $18 to $45 | | Uninsured, telehealth patient | 503A compounded progesterone via partnered pharmacy | ~$25 | | Medicare Part D | Check plan formulary; generics commonly Tier 2 | $20 to $45 |

Can I Get Oral Micronized Progesterone via Telehealth in Kansas?

Yes. Kansas law permits telehealth prescribing of oral micronized progesterone for established clinical relationships where the prescriber has conducted an appropriate evaluation. Since the COVID-era DEA flexibilities, controlled-substance prescribing via telehealth has been more complex, but oral micronized progesterone is not a controlled substance, so standard telehealth prescribing rules apply.

Kansas Telehealth Rules for Non-Controlled Prescriptions

Kansas Statute 65-4920 governs telemedicine. A prescriber licensed in Kansas may issue a prescription following a synchronous audio-video visit that allows real-time evaluation. Asynchronous (store-and-forward) encounters may also support a prescription if the platform can demonstrate the clinical standard of care was met, though synchronous visits are lower-risk from a prescribing standpoint.

What a Telehealth Evaluation for HRT Should Include

A complete HRT evaluation via telehealth should cover menstrual history, uterine anatomy (hysterectomy status determines whether progesterone is needed at all), cardiovascular risk factors, personal and family cancer history, and current medications. Baseline labs, typically TSH, FSH, estradiol, and a complete metabolic panel, may be ordered remotely with results reviewed before the prescription is issued. The Endocrine Society's clinical practice guideline on menopause recommends individualized risk-benefit assessment before initiating HRT.

The Endocrine Society guideline states: "Individualized management is essential; the decision to use menopausal hormone therapy and the choice of preparation should be based on each woman's symptoms, risks, and preferences."

Kansas-Specific Pharmacy Resources

Several Kansas resources may help patients locate affordable oral micronized progesterone.

State Pharmaceutical Assistance

Kansas does not operate a general state pharmaceutical assistance program (SPAP) equivalent to those in states like Pennsylvania or New York. The Kansas Department of Health and Environment administers several disease-specific drug programs, none of which cover menopausal HRT medications. Patients with very low income who do not qualify for Medicaid should check NeedyMeds.org for manufacturer patient assistance programs (PAPs).

AbbVie Patient Assistance Program

AbbVie's myAbbVie Assist program covers Prometrium for patients who are uninsured or underinsured and meet income thresholds (generally at or below 400% of the federal poverty level). Applications require proof of Kansas residency, income documentation, and a prescriber's signature. Processing typically takes two to four weeks for initial approval.

Local Health Departments and FQHCs

Federally qualified health centers (FQHCs) in Kansas, including HealthCore Clinic in Wichita and Heartland Community Health Center in Lawrence, use a sliding-fee scale and may be able to prescribe and dispense progesterone at dramatically reduced cost for qualifying patients. FQHCs participate in the 340B drug pricing program, which gives them access to deeply discounted acquisition prices that they pass on to low-income patients.

Side Effects and Safety Considerations That Affect Cost Decisions

Oral micronized progesterone is generally well tolerated at standard doses. Drowsiness is the most commonly reported side effect at 200 mg, which is why the nightly dosing schedule aligns with both clinical benefit and patient comfort. Patients who experience significant sedation may find the 100 mg continuous regimen equally effective with less daytime carryover.

Peanut Oil Excipient Allergy

Prometrium capsules contain peanut oil. Patients with documented peanut allergies should not use Prometrium or any generic that uses the same peanut oil carrier. A compounded progesterone capsule in a different oil base, such as sunflower oil or MCT oil, is the appropriate alternative and represents a clinically valid reason to request a compounded product rather than the commercial brand. This exception can also support a PA justifying coverage of compounding costs.

Drug Interactions

Oral micronized progesterone is metabolized primarily through CYP3A4. Medications that induce CYP3A4, including rifampin, carbamazepine, and phenytoin, may reduce progesterone blood levels. Inhibitors such as ketoconazole or ritonavir may increase levels. Patients on polypharmacy regimens should have their progesterone dose reviewed by a pharmacist or prescriber familiar with CYP450 interactions. The NIH Drug Interaction Database is a reliable reference for checking specific combinations.

Monitoring and Follow-Up: How Often Do Kansas Patients Need Office Visits?

A patient stabilized on oral micronized progesterone for HRT typically requires a follow-up visit every 6 to 12 months. Most Kansas telehealth platforms charge $50 to $150 per follow-up visit, and some bundle the follow-up cost into a monthly subscription of $60 to $100. Annual lab work, pelvic exam referral if clinically indicated, and mammography coordination may add to the total annual cost of care but are generally covered under ACA preventive care mandates for commercially insured Kansas women.